141 related articles for article (PubMed ID: 27132004)
1. Electrochemical chip-based genomagnetic assay for detection of high-risk human papillomavirus DNA.
Bartosik M; Durikova H; Vojtesek B; Anton M; Jandakova E; Hrstka R
Biosens Bioelectron; 2016 Sep; 83():300-5. PubMed ID: 27132004
[TBL] [Abstract][Full Text] [Related]
2. Cervical samples dried on filter paper and dried vaginal tampons can be useful to investigate the circulation of high-risk HPV in Congo.
Alidjinou EK; Ebatetou-Ataboho E; Sané F; Moukassa D; Dewilde A; Hober D
J Clin Virol; 2013 Jun; 57(2):161-4. PubMed ID: 23478164
[TBL] [Abstract][Full Text] [Related]
3. Genomagnetic LAMP-based electrochemical test for determination of high-risk HPV16 and HPV18 in clinical samples.
Bartosik M; Jirakova L; Anton M; Vojtesek B; Hrstka R
Anal Chim Acta; 2018 Dec; 1042():37-43. PubMed ID: 30428986
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the analytical and clinical performances of Abbott RealTime High Risk HPV, Hybrid Capture 2, and DNA Chip assays in gynecology patients.
Park S; Kang Y; Kim DG; Kim EC; Park SS; Seong MW
Diagn Microbiol Infect Dis; 2013 Aug; 76(4):432-6. PubMed ID: 23791386
[TBL] [Abstract][Full Text] [Related]
5. High-risk human papillomavirus genotype detection by electrochemical DNA chip method.
Chansaenroj J; Theamboonlers A; Chinchai T; Junyangdikul P; Swangvaree S; Karalak A; Takahashi M; Nikaido M; Gemma N; Poovorawan Y
Asian Pac J Cancer Prev; 2012; 13(4):1151-8. PubMed ID: 22799297
[TBL] [Abstract][Full Text] [Related]
6. HPV genotyping linear assay test comparison in cervical cancer patients: implications for HPV prevalence and molecular epidemiology in a limited-resource area in Bandung, Indonesia.
Panigoro R; Susanto H; Novel SS; Hartini S; Sahiratmadja E
Asian Pac J Cancer Prev; 2013; 14(10):5843-7. PubMed ID: 24289587
[TBL] [Abstract][Full Text] [Related]
7. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.
Castle PE; Reid J; Dockter J; Getman D
J Clin Virol; 2015 Aug; 69():52-5. PubMed ID: 26209379
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic methods and techniques in cervical cancer prevention Part II: Molecular diagnostics of HPV infection.
Vince A; Lepej SZ
Med Glas (Zenica); 2010 Feb; 7(1):18-25. PubMed ID: 20387720
[TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of the infection with human papillomavirus in women].
Li AX; Yin R; Zhong BY; Hao F
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):49-52. PubMed ID: 16816863
[TBL] [Abstract][Full Text] [Related]
10. cobas 4800 HPV Test, a real-time polymerase chain reaction assay for the detection of human papillomavirus in cervical specimens.
Isidean SD; Coutlée F; Franco EL
Expert Rev Mol Diagn; 2014 Jan; 14(1):5-16. PubMed ID: 24308341
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the clinical performance of restriction fragment mass polymorphism (RFMP) and Roche linear array HPV test assays for HPV detection and genotyping.
Lee HP; Cho W; Bae JM; Shin JY; Shin SK; Hwang SY; Min KT; Kim SN; Lee SJ; Kim SO; Yoo WD; Hong SP
J Clin Virol; 2013 Jun; 57(2):130-5. PubMed ID: 23410688
[TBL] [Abstract][Full Text] [Related]
12. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
13. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus prevalence in women with normal cytology and with cervical cancer in Natal, Brazil.
Fernandes JV; Meissner Rde V; Carvalho MG; Fernandes TA; Azevedo PR; de Azevedo JW; de Araújo JM
Mol Med Rep; 2011; 4(6):1321-6. PubMed ID: 21887467
[TBL] [Abstract][Full Text] [Related]
15. comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.
van Ham MA; Bakkers JM; Harbers GK; Quint WG; Massuger LF; Melchers WJ
J Clin Microbiol; 2005 Jun; 43(6):2662-7. PubMed ID: 15956381
[TBL] [Abstract][Full Text] [Related]
16. High-risk HPV DNA testing and HPV-16/18 genotyping: what is the clinical application?
Twiggs LB; Hopkins M
J Low Genit Tract Dis; 2011 Jul; 15(3):224-30. PubMed ID: 21716051
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
18. Electrochemical detection of human papillomavirus DNA type 16 using a pyrrolidinyl peptide nucleic acid probe immobilized on screen-printed carbon electrodes.
Jampasa S; Wonsawat W; Rodthongkum N; Siangproh W; Yanatatsaneejit P; Vilaivan T; Chailapakul O
Biosens Bioelectron; 2014 Apr; 54():428-34. PubMed ID: 24300785
[TBL] [Abstract][Full Text] [Related]
19. Electrochemical genosensor array for the simultaneous detection of multiple high-risk human papillomavirus sequences in clinical samples.
Civit L; Fragoso A; Hölters S; Dürst M; O'Sullivan CK
Anal Chim Acta; 2012 Feb; 715():93-8. PubMed ID: 22244172
[TBL] [Abstract][Full Text] [Related]
20. Comparison between the Abbott RealTime High Risk HPV assay and the Hybrid Capture 2 assay for detecting high-risk human papillomavirus DNA in cervical specimens.
Kaliterna V; Židovec Lepej S; Vince A
J Med Microbiol; 2009 Dec; 58(Pt 12):1662-1663. PubMed ID: 19661205
[No Abstract] [Full Text] [Related]
[Next] [New Search]
